Hochschulschrift
Controlling Hyperglycemia: Discovery of Novel Small α-Amylase Inhibitors Using Structure-Based Virtual Screening
- Weitere Titel
-
Kontrolle erhöhten Blutzuckerspiegels: Entwicklung neuer niedermolekularer α-Amylase-Inhibitoren durch strukturbasiertes virtuelles Screening
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Berlin, Freie Universität Berlin, Diss., 2014
- Schlagwort
-
Arzneimittelentwicklung
Arzneimitteldesign
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin
- (wer)
-
Freie Universität Berlin
- (wann)
-
2014
- Urheber
-
Al-Asri, Jamil
- URN
-
urn:nbn:de:kobv:188-fudissthesis000000097948-8
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:53 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Al-Asri, Jamil
- Freie Universität Berlin
Entstanden
- 2014
Ähnliche Objekte (12)
Structure-based virtual screening using index technology
Structure-Based Virtual Screening Using Index Technology
Analysis of ligand- and structure-based virtual screening data
Structural Analysis of 20S Proteasome and Development of Structure-Based Virtual Screening Methods
Structural analysis of 20S proteasome and development of structure-based virtual screening methods
Biomolecular simulations in structure-based drug discovery
Emerging chemical patterns for virtual screening and knowledge discovery
Structure‐based screening of tetrazolylhydrazide inhibitors versus KDM4 histone demethylases
Kernel learning for ligand-based virtual screening: discovery of a new PPARgamma agonist
Structure-Based Discovery of Mouse Trace Amine-Associated Receptor 5 Antagonists
A novel class of Schistosoma mansoni histone deacetylase 8 (HDAC8) inhibitors identified by structure-based virtual screening and in vitro testing
Decomposing compounds enables reconstruction of interaction fingerprints for structure‑based drug screening
Structure-based virtual screening using index technology
Structure-Based Virtual Screening Using Index Technology
Analysis of ligand- and structure-based virtual screening data
Structural Analysis of 20S Proteasome and Development of Structure-Based Virtual Screening Methods
Structural analysis of 20S proteasome and development of structure-based virtual screening methods
Biomolecular simulations in structure-based drug discovery
Emerging chemical patterns for virtual screening and knowledge discovery
Structure‐based screening of tetrazolylhydrazide inhibitors versus KDM4 histone demethylases
Kernel learning for ligand-based virtual screening: discovery of a new PPARgamma agonist
Structure-Based Discovery of Mouse Trace Amine-Associated Receptor 5 Antagonists
A novel class of Schistosoma mansoni histone deacetylase 8 (HDAC8) inhibitors identified by structure-based virtual screening and in vitro testing
Decomposing compounds enables reconstruction of interaction fingerprints for structure‑based drug screening
Structure-based virtual screening using index technology
Structure-Based Virtual Screening Using Index Technology
Analysis of ligand- and structure-based virtual screening data
Structural Analysis of 20S Proteasome and Development of Structure-Based Virtual Screening Methods
Structural analysis of 20S proteasome and development of structure-based virtual screening methods
Biomolecular simulations in structure-based drug discovery
Emerging chemical patterns for virtual screening and knowledge discovery
Structure‐based screening of tetrazolylhydrazide inhibitors versus KDM4 histone demethylases
Kernel learning for ligand-based virtual screening: discovery of a new PPARgamma agonist
Structure-Based Discovery of Mouse Trace Amine-Associated Receptor 5 Antagonists
A novel class of Schistosoma mansoni histone deacetylase 8 (HDAC8) inhibitors identified by structure-based virtual screening and in vitro testing